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Relationship Between Functional Preservation after
Segmentectomy and Volume-Reduction Effects after
Lobectomy in Stage I Non-small Cell Lung Cancer Patients
with Emphysema
Kosuke Kashiwabara, MD,* Ji-Ichiro Sasaki, MD,* Tsuyoshi Mori, MD,† Hiroaki Nomori, MD,†
Kazuhiko Fujii, MD,* and Hirotsugu Kohrogi, MD*
Objectives: To evaluate whether functional preservation after seg-
mentectomy has a greater advantage of pulmonary functions than
volume-reduction effects after lobectomy in patients with emphy-
sema with clinical T1N0 non-small cell lung cancer (NSCLC).
Patients and Methods: Between January 2000 and December 2006,
47 cases of lobectomy and 71 cases of segmentectomy were per-
formed in patients with stage I NSCLC using intraoperative sentinel
node identification. The postoperative change of the forced expira-
tory volume in 1 second (FEV1) 6 months after segmentectomy
was compared with that of 6 months after lobectomy. The difference
in the FEV1 between after segmentectomy and after lobectomy was
evaluated according to the ratio of the estimated postoperative FEV1
to the predicted normal value of FEV1 (%ppoFEV1).
Results: In 50 patients with the preoperative FEV1% less than 70%,
there was no difference in the FEV1 between the segmentectomy
group (n  30) and the lobectomy group (n  20). In 36 patients
with emphysema diagnosed by high-resolution chest computed to-
mography, a negative linear correlation between the %ppoFEV1 and
the FEV1 was found in the lobectomy subgroup (n  16, r
2 
0.508, p  0.0012), but not in the segmentectomy subgroup (n 
20). When patients with emphysema had the %ppoFEV1 more than
or equal to 70%, the FEV1 had a tendency to be smaller in the
segmentectomy subgroups than in the lobectomy subgroups.
Conclusion: Segmentectomy should be considered in patients with
cT1N0 NSCLC with a normal (80%) predicted postoperative
FEV1. In patients with a %ppoFEV1 under 70%, segmentectomy
offers no functional advantages over lobectomy.
Key Words: Segmentectomy, Lobectomy, Forced expiratory vol-
ume in 1 second (FEV1), Functional preservation, Volume-reduction
effects.
(J Thorac Oncol. 2009;4: 1111–1116)
In patients with peripheral T1N0 non-small cell lung cancer(NSCLC), a limited resection (segmentectomy or wedge
resection) was related to the higher death rate and local
recurrence rate.1 Thus, lobectomy is still considered as a
standard surgery in patients with NSCLC . In contrast, when
the surgical indication was limited to patients with stage IA
NCSLC with tumor smaller than or equal to 20 mm, many
studies recently have shown that the postoperative recurrence
rate was not higher in patients who had segmentectomy than
who had lobectomy.2–6 In addition, because segmentectomy
has been reported to have significantly a better functional
preservation as compared with lobectomy,7,8 segmentectomy
should be considered as an acceptable alternative procedure
for patients with clinical (c) T1N0 NSCLC with tumor less
than or equal to 20 mm.
Lung cancer is frequently associated with pulmonary
emphysema. The severe impairment of pulmonary functions
caused by pulmonary emphysema contraindicated surgical
treatment for lung cancer. Lung volume-reduction surgery
(LVRS) has been proposed as a palliative treatment for
patients with severe emphysema.9,10 This method showed that
the forced expiratory volume in 1 second (FEV1) increased
after lobectomy because the resection of disabling emphyse-
matous lobe improved airflow limitation and reduced the
work of breathing, which is called volume-reduction effects.
DeMeester et al.11 reported that this improvement obtained by
LVRS extend the indication of surgical treatment for patients
with lung cancer with severe emphysema, and Carretta et al.12
showed that in patients with lung cancer with emphysema,
the FEV1 may remain unchanged or even increase after
lobectomy.
However, it is not clear which is most suitable for
surgical treatment in patients with stage I NSCLC with
emphysema, segmentectomy or lobectomy. The purpose of
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this study was to evaluate whether the functional preservation
after segmentectomy has a larger advantage of pulmonary
functions than the volume-reduction effects after lobectomy
in patients with emphysema with a resectable NSCLC.
PATIENTS AND METHODS
Indication for Segmentectomy or Lobectomy
in Patients with NSCLC
During the 7-year period from January 1, 2000, to
December 31, 2006, this study enrolled 118 consecutive
patients with a peripheral lung tumor that was surgically
given a diagnosis of pathologic (p) stage I NSCLC and who
satisfied four conditions; (1) pulmonary function tests were
performed before surgery and 6 months after surgery, (2) the
Eastern Cooperative Oncology Group performance status
(PS) after surgery is 0 or 1, (3) lung cancer does not locate in
the right middle lobe, and (4) the ratio of the vital capacity to
the predicted value (%VC) is more than or equal to 80%. The
indications of segmentectomy, lobectomy, and/or mediastinal
lymph node dissection were determined using sentinel node
identification in patients with stage I NSCLC.12–14 Techne-
tium-99m tin colloid was injected into the peritumoral region
before surgery. When an intraoperative frozen material of
sentinel nodes identified by measuring radioactive tracer
uptake did not pathologically have metastasis, segmentec-
tomy was performed and mediastinal lymph node dissection
was omitted in patients with T1N0 NSCLC. Both lobectomy
and mediastinal lymph node dissection were performed when
the tumor was more than 30 mm in diameter or the result of
sentinel node identification was positive. They were staged
according to the guidelines of the Union Internationale Con-
tre le Cancer tumor, node, metastasis classification of malig-
nant tumors. Informed consent was obtained from all patients,
at the same time we explained the procedure of surgical
treatments.
Classification of Chronic Obstructive
Pulmonary Disease and Diagnosis of
Emphysema
The spirometric function measurements in all subjects
were done before surgery and 6 months after surgery using a
CHESTAC-33 spirometer (Chest Co., Ltd., Tokyo, Japan).
Measurements of the VC, the %VC, the forced VC (FVC),
the FEV1, the ratio of the FEV1 to the FVC (FEV1%), and the
ratio of the FEV1 to the predicted value (%FEV1) were based
on two satisfactory maximal forced expiratory maneuvers
performed with the subjects in a standing position. According
to the spirometric classification of chronic obstructive pul-
monary disease (COPD) severity,15 mild disease is defined as
cases who satisfied both the conditions of the FEV1% less
than 70% and the %FEV1 more than or equal to 80%,
moderate disease is defined as the FEV1% less than 70% and
the %FEV1 50% to 80%, and severe disease is defined as the
FEV1% less than 70% and the %FEV1 30% to 50%. Each
emphysema was diagnosed by a pulmonologist and a diag-
nostic radiologist using additional tests of high-resolution
chest computed tomography scans. Distribution of emphy-
sema was classified into two types; predominantly upper lobe
type and predominantly nonupper lobe type (including pre-
dominantly lower type, predominantly superior segments of
lower lobe type, and diffuse type).
Indication for Surgical Treatment in COPD or
Patients with Emphysema with Stage I NSCLC
It is well known that a mortality rate of less than 5%
can be achieved if the preoperative FEV1 is more than 1.5
liter in patients who were undergoing lobectomy.16,17 When
the preoperative FEV1 is less than 1.5 liter in COPD or
patients with emphysema being considered for lung cancer
resection, we calculated the estimated postoperative FEV1
(epoFEV1) and the estimated diffusing capacity of the lung
for carbon monoxide (epoDLCO).18 The epoFEV1 or epoDLCO
was calculated by the formula: the preoperative value of
FEV1 or DLCO  (1[the number of functional segments to
be resected]/[the total number of functional segments]). It has
been reported that the risk for perioperative death and car-
diopulmonary complications after lobectomy do not increase
in patients who satisfied the three conditions: %ppoFEV1
(epoFEV1/predicted normal value of FEV1) more than 40%,
%ppoDLCO (epoDLCO/predicted normal value of DLCO) more
than 40%, and oxygen saturation (SaO2) more than 90%.16 In
addition, a stair climbing test for evaluating the indications of
lung resection has been reported to be a safe and economical
exercise test and be the best predictor of cardiopulmonary
complications after lung resection.19 In this study, we decided
that lobectomy could be performed in patients who satisfied
these two conditions of the %ppoFEV1 more than 40% and
SaO2 more than 90% and who were able to climb an altitude
of more than 12 m.
Statistical Analysis
Statistical analysis was performed on a Macintosh com-
puter with a Stat View J 5.0 statistical program (Abacus
Concepts Inc., CA). A change of postoperative pulmonary
function was calculated by the formula: ([data 6 months after
surgery]  [data before surgery])/(data before surgery) 
100. Differences between the two independent samples were
tested using the Mann-Whitney U test. Analysis of categorical
data was performed with Fisher’s exact probability test. Analysis
of linear correlation was performed with the Pearson’s correla-
tion coefficient test. A p value of less than 0.05 was considered
to indicate a statistically significant difference.
RESULTS
Patient Characteristics
There were 68 patients with normal spirometric values
and 50 patients with airflow limitations (FEV1% 70%).
Additional high-resolution computed tomography scans
showed 36 (72%) of 50 patients with the airflow limitations
had pulmonary emphysema. The other 14 cases were never
smokers and had a history of bronchial asthma. Fourteen
(28%) of 50 patients with the airflow limitations had the
preoperative FEV1 less than 1.5 liter, but all of them satisfied
the two conditions of the %ppoFEV1 more than 40% and
SaO2 more than 90% and who were able to climb an altitude
of more than 12 m.
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Forty-seven patients underwent lobectomy (lobectomy
group) and the other 71 patients underwent segmentectomy
(segmentectomy group). Six patients with pT2N0 NSCLC
underwent segmentectomy because their tumors were preop-
eratively evaluated to be less than or equal to 30 mm. There
were no differences between the two groups in their gender,
the percentage of patients with PS 0, emphysema cases,
nonsmokers, histologic type of NSCLC, and pulmonary func-
tion before surgery. The average maximum dimensions of
tumors were smaller and the percentages of patients with
pT1N0 were higher in the segmentectomy group than in the
lobectomy group. The mean number of the resected segments
in the lobectomy group was three times higher than that in the
segmentectomy group. Right upper lobe was resected in 49%
of patients who underwent lobectomy and in 58% of patients
with NSCLC in an area of the right upper lobe (Table 1).
Analysis of Postoperative Pulmonary Functions
In patients with the normal spirometric values, the
postoperative change of both the FVC (FVC) and the FEV1
(FEV1) was smaller in the segmentectomy group than in the
lobectomy group (Figure 1). In cases with the airflow limi-
tations, the FVC had a tendency to be smaller in the
segmentectomy group than in the lobectomy group, but there
was no difference in the FEV1 between the two groups
(Figure 2).
Between the patients with emphysema who underwent
lobectomy (lobectomy subgroup) and the patients with em-
physema who underwent segmentectomy (segmentectomy
subgroup), there were no differences in the gender, the
percentage of PS 0 patients, cases with mild emphysema, and
histologic type of NSCLC. The percentage of patients with
upper lobe type emphysema was higher in the lobectomy
subgroup than in the segmentectomy subgroup. The mean
values of the %VC, FEV1, and %FEV1 were lower in the
lobectomy subgroup than in the segmentectomy subgroup
(Table 2). There were no operative deaths. Prolonged air leak
(up to 14 days) occurred in two moderate patients with
emphysema who underwent segmentectomy and postopera-
tive bacterial pneumonia occurred in a mild patient with
emphysema who underwent lobectomy.
FIGURE 1. Postoperative change of the
FVC and the FEV1 between the lobectomy
group and the segmentectomy group in
patients with stage I non-small cell lung
cancer with the normal spirometric values.
FVC, forced vital capacity; FEV1, forced ex-
piratory volume in 1 second; FVC, post-
operative change of the FVC; FEV1, post-
operative change of the FEV1.
TABLE 1. Univariate Analysis in p-Stage I Non-small Cell
Lung Cancer Patients Who Underwent Lobectomy and Who
Underwent Segmentectomy
Lobectomy
(n  47), n (%)
Segmentectomy
(n  71), n (%) p
Age: median (range) 73 (48–83) 70 (32–90)
Gender: male 26 (55) 35 (49) 0.6507
Performance status: 0 44 (94) 61 (86) 0.3136
Nonsmokers 20 (43) 37 (52) 0.4070
Comorbidity
Emphysema 16 (34) 20 (28) 0.6354
Pulmonary function tests
before surgery
VC (l) 3.04  0.77 3.06  0.70 0.8425
%VC (%) 108.8  20.0 111.5  12.3 0.3144
FVC (l) 3.02  0.77 3.06  0.68 0.3144
FEV1 (l) 2.11  0.62 2.15  0.53 0.7351
%FEV1 (%) 107.0  24.1 109.4  20.8 0.5663
FEV1% 70.3  13.0 70.6  10.2 0.8961
Histological type of
lung cancer
Atypical adenomatous
hyperplasia
0 (0) 4 (6) 0.2560
Adenocarcinoma 34 (72) 57 (80) 0.4345
Squamous cell
carcinoma
9 (19) 8 (11) 0.3546
Others 4 (9) 2 (3) 0.3420
Pathological stage:
pT1N0
32 (68) 65 (92) 0.0026
Tumor size (mm) 26.3  12.1 16.1  7.7 0.0001
Number of resected
segments
3.9  1.0 1.2  0.5 0.0001
Locations for
resections
Right upper 23 (49) 17 (24) 0.0091
Left upper 9 (19) 21 (30) 0.2901
Right lower 10 (21) 21 (30) 0.4299
Left lower 5 (11) 12 (16) 0.4960
VC, vital capacity; %VC, the ratio of the VC to the predicted value; FVC, forced
vital capacity; FEV1, forced expiratory volume in one second; FEV1, the ratio of the
FEV1 to the predicted value; FEV1%, the ratio of the FEV1 to the FVC.
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According to the coincidence (or not) between the
resected area and the predominant emphysema area, there
were 24 patients with emphysema and cancer mainly local-
ized in the same lobe (23 cases with upper lobe type emphy-
sema and one case with nonupper lobe type emphysema). In
19 patients with mild upper lobe type emphysema, 10 cases
underwent lobectomy (eight cases with lung cancer of the
right side) and nine cases underwent segmentectomy (seven
cases with lung cancer of the left side). Lobectomy was
performed in all five patients with moderate emphysema.
Eight of nine patients with emphysema and cancer localized
in different lobes and three patients with diffuse type emphy-
sema underwent segmentectomy for tumor resection (Table
3). In 23 patients with both cancer and emphysema localized
in the same upper lobe, there was no difference in the FEV1
between the lobectomy subgroup (n  14) and the segmen-
tectomy subgroup (n  9) (15.6  15.2% versus 13.4 
9.9%, p  0.7156).
A negative linear correlation between the %ppoFEV1
and the FEV1 was found in the lobectomy subgroup (r
2 
0.508, p  0.0012), but not in the segmentectomy subgroup
(n  20, p  0.2037) (Figure 3). In addition, this correlation
was not detected in both patients with the airflow limitations
other than emphysema (n  14) and patients with the normal
spirometric values (n  68). In 36 patients with emphysema,
p values for comparison of the FEV1 between the patients
who underwent segmentectomy and the patients who under-
went lobectomy were evaluated using different cut off values
of the %ppoFEV1. When patients with emphysema had the
%ppoFEV1 of larger than or equal to 70%, the FEV1 had a
tendency to be lower in the segmentectomy subgroup than in
the lobectomy subgroup (Table 4).
DISCUSSION
In this study, we found that segmentectomy had a
tendency to have a greater advantage in pulmonary functions
than lobectomy in patients with emphysema with %ppoFEV1
more than equal to 70%. There was no difference in the
FEV1 after segmentectomy between the patients with em-
physema and the patients with normal spirometric values
(13.4  8.6% versus 12.9  8.7%, p  0.9205). Inter-
FIGURE 2. Postoperative change of the
FVC and the FEV1 between the lobec-
tomy group and the segmentectomy
group in patients with stage I non-small
lung cancer with the airflow limitations
(the FEV1% 70%). FVC, forced vital ca-
pacity; FEV1, forced expiratory volume in
1 second; FVC, postoperative change of
the FVC; FEV1, postoperative change of
the FEV1.
TABLE 2. Univariate Analysis in p-Stage I Non-small Cell
Lung Cancer Patients with Emphysema Who Underwent
Lobectomy and Who Underwent Segmentectomy
Lobectomy
(n  16), n (%)
Segmentectomy
(n  20), n (%) p
Age: median (range) 75 (49–83) 73 (56–82)
Gender: male 14 (88) 17 (85) 0.9999
Performance status: 0 14 (88) 16 (80) 0.8808
Emphysema
Mild disease 11 (69) 17 (85) 0.4461
Moderate disease 5 (31) 3 (15)
Distribution of emphysema
on HRCT
Upper lobe type 14 (88) 9 (45) 0.0221
Nonupper lobe type 2 (12) 11 (55)
Pulmonary function tests
before surgery
VC (l) 3.11  0.75 3.50  0.73 0.1428
%VC (%) 102.4  14.0 113.5  15.9 0.0466
FVC (l) 3.06  0.74 3.49  0.69 0.0826
FEV1 (l) 1.72  0.53 2.14  0.53 0.0177
%FEV1 (%) 84.5  17.2 98.4  18.6 0.0385
FEV1% 56.3  10.1 61.1  6.9 0.1565
Histological type of
lung cancer
Adenocarcinoma 8 (50) 12 (60) 0.7929
Squamous cell carcinoma 7 (44) 7 (35) 0.8484
Others 1 (6) 1 (5) 0.9999
Pathological stage: T1N0 10 (62) 16 (80) 0.4293
Tumor size (mm) 28.9  15.4 20.0  9.0 0.0825
Number of resected segments 3.7  1.0 1.3  0.4 0.0001
Locations for resections
Right upper 10 (63) 4 (20) 0.0241
Left upper 4 (25) 7 (35) 0.7771
Right lower 1 (6) 5 (25) 0.2937
Left lower 1 (6) 4 (20) 0.4836
VC, vital capacity; %VC, ratio of the VC to the predicted value; FVC, forced vital
capacity; FEV1, forced expiratory volume in one second; % FEV1, ratio of the FEV1 to
the predicted value; FEV1%, ratio of the FEV1 to the FVC.
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estingly, there were some patients with emphysema receiving
lobectomy who had a greater advantage in postoperative
pulmonary functions than the functional preservation after
segmentectomy, because their FEV1 after lobectomy im-
proved with the decreasing values of the %ppoFEV1. We
speculated that this increase in FEV1 was due to the effect of
volume-reduction surgery. It is therefore important to decide
which is more suitable for cT1N0 NSCLC treatments in
patients with emphysema with different %ppoFEV1 values
segmentectomy or lobectomy.
The epoFEV1 is calculated by estimating the amount of
functioning lung tissue that would be lost with the surgical
resection and is used as a surgical indicator of lobectomy for
patients with lung cancer with impaired pulmonary func-
tions.16,17 We evaluated the difference in the FEV1 between
the patients who had segmentectomy and the patients who
had lobectomy using different cut off values of the
%ppoFEV1. Our results showed that segmentectomy had an
advantage in pulmonary functions compared with lobectomy
in patients with emphysema with the %ppoFEV1 more than
equal to 80%. When the tumor is less than 30 mm in
diameter, segmentectomy should be considered. Conversely,
patients with emphysema with the %ppoFEV1 less than 70%
did not improve residual pulmonary functions after segmen-
tectomy. Therefore, lobectomy should be considered in those
patients, because segmental resection of the disabling emphy-
sematous lobe may increase the risk of the postoperative
complications. In addition, it has been recommended that
combined LVRS and lung cancer resection should be consid-
ered in patients with lung cancer in an area of severe upper
lobe type emphysema with %ppoFEV1 more than 20% and
%DLCO more than 20%.17,20,21 Although patients with severe
emphysema were not included in this study, we also found
volume-reduction effects after upper lobectomy in patients
with both lung cancer and emphysema localized in the same
upper lobe. It is not clear whether combined LVRS and
segmentectomy should be considered in patients with upper
lobe emphysema with cT1N0 NSCLC located in the different
lobe. We cannot evaluate this because eight patients with
upper lobe emphysema and lung cancer localized in different
lobes underwent segmentectomy for tumor resection.
This study has three limitations. First, this study was
retrospective and not randomized. Second, in patients with
emphysema, the preoperative FEV1 was lower in the lobec-
tomy subgroup than in the segmentectomy subgroup, which
showed lobectomy was performed in patients with the lower
spirometric values. However, this bias did not affect our
results because we evaluated the difference in the FEV1
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FIGURE 3. Correlation between the postoper-
ative change of the FEV1 and the %ppoFEV1.
Analysis of a linear correlation was performed
with the Pearson’s correlation coefficient test.
FEV1, forced expiratory volume in 1 second;
%ppoFEV1, ratio of the estimated postoperative
FEV1 to the predicted normal value of FEV1.
TABLE 3. Surgical Procedures in Patients with Lung Cancer
and Emphysema Mainly Localized in the Same Lobe, in
Patients with Lung Cancer and Emphysema Localized in
Different Lobes and in Patients with Diffuse Type
Emphysema
Distribution of
Emphysema
Surgical
Procedures
EM and LC
in Same
Lobe
(n  24)
EM and LC
in Different
Lobes
(n  9)
Diffuse Type
EM (n  3)
Mild disease
(n  28)
Upper lobe
(n  19)
Lob 10 (8R, 2L) 0 —
Seg 9 (2R, 7L) 0 0
Nonupper lobe
(n  9)
Lob 0 1 (1L) 0
Seg 0 8 (5R, 3L) 0
Moderate disease
(n  8)
Upper lobe
(n  4)
Lob 4 (2R, 2L) 0 —
Nonupper lobe
(n  4)
Lob 1 (1R) 0 0
Seg 0 0 3 (2R, 1L)
EM, emphysema; LC, lung cancer; Lob, lobectomy; Seg, segmentectomy; L, light
side; R, right side.
TABLE 4. Comparison of the Postoperative Change of the
FEV1 (FEV1) Between Patients Who Had Segmentectomy
and in Patients Who Had Lobectomy Using Different Cut Off
Values of the %ppoFEV1
%ppoFEV1
FEV1 (%)
pLobectomy Segmentectomy
50 13.8  12.6 (n  14) 13.3  9.5 (n  20) 0.9072
55 17.7  8.8 (n  11) 13.3  9.5 (n  20) 0.2193
60 17.7  8.8 (n  11) 13.1  9.8 (n  19) 0.2142
65 17.7  8.8 (n  11) 12.3  9.3 (n  18) 0.1332
70 19.4  8.8 (n  9) 12.3  9.3 (n  18) 0.0665
75 20.1  8.4 (n  7) 12.1  9.5 (n  17) 0.0666
80 21.4  8.5 (n  6) 11.2  8.0 (n  14) 0.0199
FEV1, forced expiratory volume in one second; %ppoFEV1, ratio of the estimated
postoperative FEV1 to the predicted normal value of FEV1.
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between the two groups using the relative reduction rate of
the postoperative FEV1, %ppoFEV1. Third, many studies
reported that segmentectomy should be considered in patients
with cT1N0 NSCLC with tumor less than or equal to 20
mm,3–5 but our patients with tumors 20 to 30 mm in diameter
also underwent segmentectomy navigated by sentinel node
identification, which were reported by Nomori et al.13 Al-
though the false-positive rate of sentinel node identification
has been reported to range from 0 to 33%,14,22–25 this rate also
did not affect our results because the purpose of this study
was to discuss sentinel node issue.
In conclusion, segmentectomy should be considered in
patients with cT1N0 NSCLC with a normal (80%) pre-
dicted postoperative FEV1. In patients with the %ppoFEV1
under 70%, segmentectomy offers no functional advantages
over lobectomy.
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